Elsevier

Biochemical Pharmacology

Volume 41, Issue 1, 1 January 1991, Pages 139-141
Biochemical Pharmacology

Short communication
In vitro effects of various cholinesterase inhibitors on acetyl- and butyrylcholinesterase of healthy volunteers

https://doi.org/10.1016/0006-2952(91)90022-WGet rights and content

First page preview

First page preview
Click to open first page preview

References (14)

There are more references available in the full text version of this article.

Cited by (83)

  • Evaluation of some biological activities of the tubers of Corydalis solida (L.) Clairv. ssp. incisa Liéden growing in Turkey

    2019, South African Journal of Botany
    Citation Excerpt :

    Galantamine increases the availability of ACh in the cholinergic synapse by competitively inhibiting the enzyme responsible for its breakdown, AChE. The binding of galantamine to AChE slows down the catabolism of ACh and, as a result, ACh levels in the synaptic cleft are increased (Thomsen et al., 1991a,b; Bores et al., 1996; Heinrich and Teoh, 2004). Therefore, current drug therapies are based on the cholinergic hypothesis.

  • Continuous infusion of physostigmine in patients with perioperative septic shock: A pharmacokinetic/pharmacodynamic study with population pharmacokinetic modeling

    2019, Biomedicine and Pharmacotherapy
    Citation Excerpt :

    The aforementioned study assessing AChE activity [45] has not reported EC50 estimates; plasma concentrations were lower than in our study and maximum enzyme inhibition did not exceed 35%. However, data from ex vivo inhibition of human erythrocytes, incubated with physostigmine, suggested an EC50 in the range of 6.7–7.4 ng/mL [55,56], which is in line with our findings. Plasma concentrations resulting from physostigmine salicylate infusion (initial bolus and continuous infusion) in patients with septic shock were found to be sufficient for about 50%–70% inhibition of erythrocyte AChE activity.

  • Interaction between substrates suggests a relationship between organophosphorus-sensitive phenylvalerate- and acetylcholine-hydrolyzing activities in chicken brain

    2014, Toxicology Letters
    Citation Excerpt :

    PMSF resistant PVase activity was also resistant to the inhibition by BW284C51 (a typical specific reversible inhibitor of AChE in mammals; Fig. 6), but BuChE inhibitors as ethopropazine (a reversible inhibitor) and iso-OMPA (an irreversible inhibitor) inhibited the PMSF resistant PVase activity. The inhibition by iso-OMPA was time progressive (Fig. 7), which indicates that this inhibition can be irreversible and it matches with the results obtained for human BuChE (Thomsen et al., 1991). Some authors have previously used these specific inhibitors in order to isolate and purify AChE (Rotundo, 1984) and BuChE (Treskatis et al., 1992) of chicken brain but in membrane fraction.

  • Role of acetylcholinesterase inhibitors and alzheimer disease

    2014, Drug Design and Discovery in Alzheimer's Disease
  • The geographic isolation of Leucojum aestivum populations leads to divergation of alkaloid biosynthesis

    2013, Biochemical Systematics and Ecology
    Citation Excerpt :

    It is gathered from the natural habitats for industrial purposes which causes increasing problems with depletion of the wild populations. Galanthamine, a reversible acetylcholinesterase (AChE) inhibitor, is marketed as a hidrobromide salt under the name of Razadine® (formerly Reminyl®) for the treatment of Alzheimer's disease (Thomsen et al., 1991). According to data presented by the Alzheimer's Association (2010) the prevalence of Alzheimer's disease will quadruple by 2050.

View all citing articles on Scopus
View full text